20-Year prevalence projections for dementia and impact of preventive policy about risk factors

European Journal of Epidemiology

Volumn 28, Issue 6, 2013, Pages 493-502

  Jacqmin Gadda, Hélène ^a,b   Alperovitch, Annick ^a,b   Montlahuc, Claire ^a,b   Commenges, Daniel ^a,b   Leffondre, Karen ^a,b   Dufouil, Carole ^a,b   Elbaz, Alexis ^c,d   Tzourio, Christophe ^a,b   Ménard, Joël ^e   Dartigues, Jean François ^a,b   Joly, Pierre ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^d LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Dementia; Incidence; Mortality; Prevalence; Projection

Indexed keywords

APOLIPOPROTEIN E4;

AGE; AGED; ARTICLE; BLOOD PRESSURE REGULATION; COHORT ANALYSIS; CONTROLLED STUDY; DEMENTIA; FEMALE; FRANCE; HEALTH CARE POLICY; HUMAN; INCIDENCE; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; MORTALITY; POPULATION SIZE; PREDICTION; PREVALENCE; PREVENTIVE HEALTH SERVICE; PUBLIC HEALTH SERVICE; RISK FACTOR; SEX DIFFERENCE; TREND STUDY;

AGE FACTORS; AGED; AGED, 80 AND OVER; DEMENTIA; FEMALE; FORECASTING; FRANCE; HEALTH POLICY; HUMANS; INCIDENCE; LIFE EXPECTANCY; MALE; ODDS RATIO; PREVALENCE; PRIMARY PREVENTION; RISK FACTORS; SEX FACTORS; TIME FACTORS;

EID: 84879836732     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-013-9818-7     Document Type: Article

References (38)

1. Gallez C. Rapport sur la maladie d alzheimer et les maladies apparentées. Office Parlementaire d'Évaluation des Politiques de Santé, Bibliothèque des Rapports Publics. http://www. assembleenationale.fr/12/rap-off/i2454.asp (2005).
2. Alzheimer-Association. Alzheimer's disease facts and figures. Alzheimers Dement. 2012;8:131-168.
3. Polidori MC, Pientka L, Mecocci P. A review of the major vascular risk factors related to alzheimer's disease. J Alzheimers Dis. 2012;32:521-530.
4. Barnes DE, Yaffe K. The projected effect of risk factor reduction on alzheimer's disease prevalence. Lancet Neurol. 2011;10(9):819-828.
5. Brookmeyer R, Gray S, Kawas C. Projections of alzheimer's disease in the united states and the public health impact of delaying disease onset. Am J Public Health 1998;88(9):1337-1342.
6. Brookmeyer R, Gray S. Methods for projecting the incidence and prevalence of chronic diseases in ageing populations: application to alzheimer's disease. Stat Med. 2000;19(11-12):1481-1493.
7. Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM. Forecasting the global burden of alzheimer's disease. Alzheimers Dement. 2007;3(3):186-191.
8. Mura T, Dartigues JF, Berr C. How many dementia cases in france and europe? Alternative projections and scenarios 2010-2050. Eur J Neurol. 2010;17(2):252-259.
9. Joly P, Commenges D, Helmer C, Letenneur L. A penalized likelihood approach for an illness-death model with interval-censored data: application to age-specific incidence of dementia. Biostatistics 2002;3(3):433-443.
10. Ostbye T, Hill G, Steenhuis R. Mortality in elderly Canadians with and without dementia: a 5-year follow-up. Neurology 1999;53(3):521-526.
11. Jagger C, Andersen K, Breteler MM, Copeland JR, Helmer C, Baldereschi M, et al. Prognosis with dementia in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 2000;54(11 supp l5):S16-S20.
12. Ramaroson H, Helmer C, Barberger-Gateau P, Letenneur L, Dartigues JF. Prevalence of dementia and Alzheimer's disease among subjects aged 75 years or over: updated results of the PAQUID cohort. Rev Neurol. 2003;159(4):405-411.
13. Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, et al. Global prevalence of dementia: a delphi consensus study. Lancet 2006;366(9503):2112-2117.
14. WHO. World health report 2002. Reducing risks, promoting healthy life. Geneva: WHO, 2002. World Health Organization, Geneva, Switzerland, http://www.who.int/whr/2002 (2002).
15. Duron E, Hanon O. Hypertension, cognitive decline and dementia. Arch Cardiovasc Dis. 2008;101(3):181-189.
16. Tolppanen AM, Solomon A, Soininen H, Kivipelto M. Midlife vascular risk factors and alzheimer's disease: evidence from epidemiological studies. J Alzheimers Dis. 2012;32:531-540.
17. Power MC, Weuve J, Gagne JJ, McQueen MB, Viswanathan A, Blacker D. The association between blood pressure and incident alzheimer disease: a systematic review and meta-analysis. Epidemiology 2011;22(5):646-659.
18. Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein e genotype and alzheimer disease. JAMA 1997;278(16):1349-1356.
19. Genin E, Hannequin D, Wallon D, Sleegers K, Hiltunen M, Combarros O, et al. Apoe and alzheimer disease: a major gene with semi-dominant inheritance. Mol Psychiatry 2011;16(9):903-907.
20. Tilvis RS, Kähönen-Väre MH, Jolkkonen J, Valvanne J, Pitkala KH, Strandberg TE. Predictors of cognitive decline and mortality of aged people over a 10-year period. J Gerontol A Biol Sci Med Sci. 2004;59(3):M268-M274.
21. Cramer PE, Cirrito JR, Wesson DW, Lee CY, Karlo JC, Zinn AE, et al. Apoe-directed therapeutics rapidly clear {beta}-amyloid and reverse deficits in ad mouse models. Science 2012;335(6075):1503-1506.
22. Strittmatter WJ. Old drug, new hope for alzheimers disease. Science 2012;335(6075):1447-1448.
23. Joly P, Touraine C, Georget A, Dartigues JF, Commenges D, Jacqmin-Gadda H. Prevalence projections of chronic diseases and impact of public health intervention. Biometrics 2013;69:109-117.
24. Keiding N. Age-specific incidence and prevalence: a statistical perspective. J R Stat Soc Series A 1991;154(3):371-412.
25. Blanpain N, Chardon O. Projections de population 2007-2060 pour la france métropolitaine: méthode et principaux résultats. Document de travail 2010;F1008. http://alexandre.cor-retraites.fr/IMG/pdf/doc-1446.pdf.
26. Commenges D, Joly P, Letenneur L, Dartigues JF. Incidence and mortality of Alzheimer's disease or dementia using an illness-death model. Stat Med. 2004;23:199-210.
27. Gompertz Benjamin. On the nature of the function expressive of the law of human mortality, and on a new mode of determining the value of life contingencies. Philos Trans R Soc Lond. 1825;115:513-583.
28. Blanpain N, Chardon O. Projections de population à l'horizon 2060. un tiers de la population âgé de plus de 60 ans. Insee première 2010;1320:1-4.
29. Peters R, Beckett N, Forette F, Tuomilehto J, Clarke R, Ritchie C, et al. Incident dementia and blood pressure lowering in the hypertension in the very elderly trial cognitive function assessment (hyvet-cog): a double-blind, placebo controlled trial. Lancet Neurol. 2008;7(8):683-689.
30. Dahlöf B, Hansson L, Lindholm LH, Schersten B, Ekbom T, Wester PO. Morbidity and mortality in the swedish trial in old patients with hypertension (stop-hypertension). Lancet 1991;338(8778):1281-1285.
31. Staessen JA, Gasowski J, Wang JG, Thijs L, Den Hond E, Boissel JP, et al. Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet 2000;355(9207):865-872.
32. Winnock M, Letenneur L, Jacqmin-Gadda H, Dallongeville J, Amouyel P, Dartigues JF. Longitudinal analysis of the effect of apolipoprotein e ε 4 and education on cognitive performance in elderly subjects: the paquid study. J Neurol Neurosurg Psychiatry 2002;72(6):794-797.
33. Law MR, Morris JK, Wald NJ, et al. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 2009;338(191):1245-1253.
34. Fratiglioni L, Launer LJ, Andersen K, Breteler MM, Copeland JR, Dartigues JF, et al. Incidence of dementia and major subtypes in europe: a collaborative study of population-based cohorts. neurologic diseases in the elderly research group. Neurology 2000;54(11 Suppl 5): S10.
35. Schrijvers EMC, Verhaaren BFJ, Koudstaal PJ, Hofman A, Ikram MA, Breteler MMB. Is dementia incidence declining? Trends in dementia incidence since 1990 in the rotterdam study. Neurology 2012;78(19):1456-1463.
36. Rocca WA, Petersen RC, Knopman DS, Hebert LE, Evans DA, Hall KS, et al. Trends in the incidence and prevalence of alzheimers disease, dementia, and cognitive impairment in the united states. Alzheimers Dement. 2011;7(1):80-93.
37. Commenges D, Joly P, Gégout-Petit A, Liquet B. Choice between semi-parametric estimators of markov and non-markov multi-state models from coarsened observations. Scand J Stat. 2006;34(1):33-52.
38. Amieva H, Le Goff M, Millet X, Orgogozo JM, Pérès K, Barberger-Gateau P, et al. Prodromal alzheimer's disease: successive emergence of the clinical symptoms. Ann Neurol. 2008;64(5):492-498.